While GOP lawmakers accused the Austin Democrat of overstating his role in passing a statewide cap on insulin copays, his Democratic colleagues said his personal battle with diabetes generated key ...

The City of Providence, along other municipalities and states, is taking big pharma to court over the price of insulin.

Penn State alleges it has been overcharged millions of dollars since 2008.

Penn State University has sued several pharmaceutical companies alleging they conspired to inflate the price of insulin and other drugs the university paid for through its insurance program. The ...

The antitrust agency paused its lawsuit against the pharmacy benefit manager while the two discuss a proposed consent ...

In a new lawsuit, Iowa Attorney General Brenna Bird alleges 18 companies have charged Iowans too much for insulin and pocketed the extra profit.

Medtronic said Monday it received 510 (k) clearance from the Food and Drug Administration for an app to connect its smart insulin pens with a glucose sensor made by Abbott.

The FDA has approved a label update for an inhaled insulin indicated for adults with type 1 or type 2 diabetes, according to ...

Penn State sues insulin makers and PBMs alleging inflated prices and seeks damages for overpayments in its self-insured health plans.

Intranasal insulin may help reduce the incidence of postoperative delirium, cognitive dysfunction, and neuroinflammation in adults, a new meta-analysis suggests.

Higher fasting insulin levels in perimenopause are associated with a younger age of onset and longer duration of VMS.

For more than a century, oral insulin has been considered a "dream" therapy for diabetes, hindered by enzymatic degradation ...